All Stories

  1. Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), November 2024, De Gruyter

    andrea vianello

  2. Serum biomarkers of remodeling in severe asthma with fixed airway obstruction and the potential role of KL-6

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), March 2023, De Gruyter

    andrea vianello

  3. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), November 2021, De Gruyter

    andrea vianello

  4. Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection

    Article • September 2021, European Respiratory Society (ERS)

    andrea vianello

  5. Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response

    Article • Expert Review of Respiratory Medicine, October 2019, Taylor & Francis

    andrea vianello

  6. A new treatment algorithm for acute exacerbation of IPF: a retrospective cohort study

    Article • September 2019, European Respiratory Society (ERS)

    andrea vianello

  7. The mutual association between dyspnea and depressive symptoms in older adults: a 4-year prospective study

    Article • Aging & Mental Health, March 2019, Taylor & Francis

    andrea vianello, Marianna Noale

  8. Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation

    Article • Current Medical Research and Opinion, January 2019, Taylor & Francis

    andrea vianello, MARGHERITA ANDRETTA